STAT Plus: Amgen’s drug — targeting an ‘undruggable’ cancer protein — shrank tumors in half of patients By ADAM FEUERSTEIN

Amgen drug shrank tumors in patients with 'undruggable' cancer protein

STAT Plus: Amgen’s drug — targeting an ‘undruggable’ cancer protein — shrank tumors in half of patients By ADAM FEUERSTEIN ADOBE Discovering drugs capable of blocking KRAS has proven difficult. The protein is spherical and nearly featureless — like that of a tennis ball. READ MORE